http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Large-Scale Dataset Incremental Association Rules Mining Model and Optimization Algorithm
Guo Yu-Dong,Li Sheng-Lin,Li Yong-Zhi,Wang Zhao-Xia,Zeng Li 보안공학연구지원센터 2016 International Journal of Database Theory and Appli Vol.9 No.4
Mining association rules is an important research direction in the field of data mining. Related studies have proposed many used to efficiently find large-scale database association rules algorithm, but the research on maintenance problem of association rules is less. Especially many transaction database is always in constant updates. Increase or decrease occurs when the database or dataset minimum support after the change, how to maintain the association rules have been, it got the attention of many researchers. Based on IFP-Growth increment of association rules mining model and to modify the FP-tree, put forward the suitable for transaction data and support the tree model of change, at the same time under different conditions is given incremental association rules mining algorithm, and reduce the frequency of the original dataset range query and query, and in a case of massive dataset multi-level tree structure decomposition, dynamic allocation rule tree branches, ensure load balancing, improve operation efficiency.
Zhao Yu Han,Zheng Yu,Sha Jie,Hua Hong Jin,Li Ke Dong,Lu Yu,Dang Yi Ni,Zhang Guo Xin 거트앤리버 소화기연관학회협의회 2023 Gut and Liver Vol.17 No.1
Background/Aims: The discrepancies between the diagnosis of preoperative endoscopic forceps biopsy (EFB) and endoscopic submucosal dissection (ESD) in patients with early gastric neoplasm (EGN) exist objectively. Among them, pathological upgrading directly influences the accuracy and appropriateness of clinical decisions. The aims of this study were to investigate the risk factors for the discrepancies, with a particular focus on pathological upgrading and to establish a prediction model for estimating the risk of pathological upgrading after EFB. Methods: We retrospectively collected the records of 978 patients who underwent ESD from December 1, 2017 to July 31, 2021 and who had a final histopathology determination of EGN. A nomogram to predict the risk of pathological upgrading was constructed after analyzing subgroup differences among the 901 lesions enrolled. Results: The ratio of pathological upgrading was 510 of 953 (53.5%). Clinical, laboratorial and endoscopic characteristics were analyzed using univariable and binary multivariable logistic regression analyses. A nomogram was constructed by including age, history of chronic atrophic gastritis, symptoms of digestive system, blood high density lipoprotein concentration, macroscopic type, pathological diagnosis of EFB, uneven surface, remarkable redness, and lesion size. The C-statistics were 0.804 (95% confidence interval, 0.774 to 0.834) and 0.748 (95% confidence interval, 0.664 to 0.832) in the training and validation set, respectively. We also built an online webserver based on the proposed nomogram for convenient clinical use. Conclusions: The clinical value of identifying the preoperative diagnosis of EGN lesions is limited when using EFB separately. We have developed a nomogram that can predict the probability of pathological upgrading with good calibration and discrimination value.
Qiu-Yan Chen,Shao-Yan Guo,Lin-Quan Tang,Tong-Yu Lu,Bo-Lin Chen,Qi-Yu Zhong,Meng-Sha Zou,Qing-Nan Tang,Wen-Hui Chen,Shan-Shan Guo,Li-Ting Liu,Yang Li,Ling Guo,Hao-Yuan Mo,Rui Sun,Dong-Hua Luo,Chong Zha 대한암학회 2018 Cancer Research and Treatment Vol.50 No.3
Purpose Little is known about combination of the circulating Epstein-Barr viral (EBV) DNA and tumor volume in prognosis of stage II nasopharyngeal carcinoma (NPC) patients in the intensity modulated radiotherapy (IMRT) era. We conducted this cohort study to evaluate the prognostic values of combining these two factors. Materials and Methods By Kaplan-Meier, we compare the differences of survival curves between 385 patients with different EBV DNA or tumor volume levels, or with the combination of two biomarkers mentioned above. Results Gross tumor volume of cervical lymph nodes (GTVnd, p < 0.001) and total tumor volume (GTVtotal, p < 0.001) were both closely related to pretreatment EBV DNA, while gross tumor volume of nasopharynx (GTVnx, p=0.047) was weakly related to EBV DNA. EBV DNA was significantly correlated with progress-free survival (PFS, p=0.005), locoregional-free survival (LRFS, p=0.039), and distant metastasis-free survival (DMFS, p=0.017), while GTVtotal, regardless of GTVnx and GTVnd, had a significant correlation with PFS and LRFS. The p-values of GTVtotal for PFS and LRFS were 0.008 and 0.001, respectively. According to GTVtotal and pretreatment EBV DNA level, patients were divided into a low-risk group (EBV DNA 0 copy/mL, GTVtotal < 30 cm3; EBV DNA 0 copy/mL, GTVtotal 30 cm3; or EBV DNA > 0 copy/mL, GTVtotal < 30 cm3) and a high-risk group (EBV DNA > 0 copy/mL, GTVtotal 30 cm3). When patients in the low-risk group were compared with those in the high-risk group, 3-year PFS (p=0.003), LRFS (p=0.010), and DMFS (p=0.031) rates were statistically significant. Conclusion Pretreatment plasma EBV DNA and tumor volume were both closely correlated with prognosis of stage II NPC patients in the IMRT era. Combination of EBV DNA and tumor volume can refine prognosis and indicate for clinical therapy.
Han Ying-Hao,Mao Ying-Ying,Yu Nan-Nan,Jin Mei-Hua,Jin Ying-Hua,Wang Ai-Guo,Zhang Yong-Qing,Shen Gui-Nan,Cui Yu-Dong,Yu Li-Yun,Lee Dong-Seok,Jo Yu-Jin,Sun Hu-Nan,Kwon Jeongwoo,권태호 한국응용생명화학회 2020 Applied Biological Chemistry (Appl Biol Chem) Vol.63 No.3
In this study, we used RNA sequencing (RNA-seq) to analyze and compare bulk cell samples from wild-type (WT) dermal mesenchymal stem cells (DMSCs) (n = 3) and Prx II knockout DMSCs (n = 3). The purpose of the study was to elucidate the role of Prx II on allogeneic immune rejection of transplanted DMSCs. The results revealed differential expression of 472 genes (176 up-regulated and 296 down-regulated; p ≤ 0.05) between the PrxII+/+ (WT) and PrxII−/− sample groups. When highly regulated genes were categorized according to the Gene Ontology (GO) molecular function classification and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, the PrxII−/− samples showed a robust downward trend in allograft rejection. The study identified 43 all immunologically rejected differentially expressed genes, of which 41 showed lower expression in the PrxII−/− vs. PrxII+/+ (WT) samples. These findings suggest that Prx II gene knockout may down-regulate the allograft rejection that occurs during DMSCs transplantation and improve the survival rate of DMSCs in the host. This study provides a new perspective on the clinical treatment of stem cell transplantation.
Somatostatin Receptors 3, 4 and 5 Play Important Roles in Gallbladder Cancer
Guo, Run-Sheng,Shi, Pei-Dong,Zhou, Jie,Chen, Yue-Yu Asian Pacific Journal of Cancer Prevention 2013 Asian Pacific journal of cancer prevention Vol.14 No.7
Expression changes of somatostatin receptor subtypes (SSTRs) including SSTR1, SSTR2, SSTR3, SSTR4 and SSTR5 in the development of gallbladder cancer were assessed with attention to relationships with clinical pathological characteristics. SSTRs in 29 gallbladder cancer and 25 normal gallbladder tissue specimens were examined by immunohistochemical staining. Differences between SSTRs expressions and clinical pathological parameters were analyzed by chi-square test. The five subtypes of SSTR were all expressed in gallbladder cancer tissues and SSTR3 presented the highest expression. SSTR5 expression was increased significantly in gallbladder cancer (P<0.05) compared with that in normal gallbladder tissue. SSTR3 expression in highly and moderately differentiated gallbladder cancer was significantly higher than that in poorly differentiated lesions (P<0.05). SSTR4 expression was lower in gallbladder cancer with lymph node metastasis than that in gallbladder cancer without lymph node metastasis (P<0.05). Therfore, these results indicated that SSRT5, SSTR3 and SSTR4 may play important roles in the formation and development of gallbladder cancer.
Yu, Yong-Jiang,Li, Yu-Min,Hou, Xu-Dong,Guo, Chao,Cao, Nong,Jiao, Zuo-Yi Asian Pacific Journal of Cancer Prevention 2012 Asian Pacific journal of cancer prevention Vol.13 No.5
Objective: Tissue factor (TF) is expressed abnormally in certain types of tumor cells, closely related to invasion and metastasis. The aim of this study was to construct a human gastric cancer cell line SGC7901 stably-transfected with human TF, and observe effects on oxaliplatin-dependent inhibition of invasion and the apoptosis induction. Methods: The target gene TF was obtained from human placenta by nested PCR and introduced into the human gastric cell line SGC7901 through transfection mediated by lipofectamine. Stably-transfected cells were screened using G418. Examples successfully transfected with TF-pcDNA3 recombinant (experimental group), and empty vector pcDNA3 (control group) were incubated with oxaliplatin. Transwell chambers were used to show change in invasive ability. Caspase-3 activity was detected using a colorimetric method and annexin-V/PI double-staining was applied to detect apoptosis. Results: We generated the human gastric cancer cell line SGC7901/TF successfully, expressing TF stably and efficiently. Compared with the control group, invasion increased, whereas caspase-3 activity and apoptosis rate were decreased in the experimental group. Conclusion: TF can enhance the invasive capacity of gastric cancer cells in vitro. Its increased expression may reduce invasion inhibition and apoptosis-inducing effects of oxaliplatin and therefore may warrant targeting for improved chemotherapy.
Combination of Cloud Computing and Internet of Things (IOT) in Medical Monitoring Systems
Yu Liu,Beibei Dong,Benzhen Guo,Jingjing Yang,Wei Peng 보안공학연구지원센터 2015 International Journal of Hybrid Information Techno Vol.8 No.12
With the fast development of cloud computing and computer science technology, the combination of the IOT and clod computing in the medical-assisted environment is urgently needed. The prior research focus more on individual development of the single technique, quite a less research on the field of medical monitoring and managing service application have been conducted. Therefore, in this paper, we study and analyze the application of cloud computing and the Internet of Things on the field of medical environment. We are trying to make the combination of the two kinds of technology monitoring and management information system in hospital. Remote monitoring cloud platform architecture model (RMCPHI) set up medical information in the first place. Then the RMCPHI architecture was analyzed. Eventually, the last effective PSOSAA algorithm proposed the hospital medical information service cloud system monitoring and management application. Experimental simulation illustrates that the proposed algorithm outperforms the other state-of-the-art algorithms. Further potential research areas are discussed.
Luminescence and thermal-quenching properties of Dy3+-doped Ba2CaWO6 phosphors
Yu, Ruijin,Shin, Dong Soo,Jang, Kiwan,Guo, Yue,Noh, Hyeon Mi,Moon, Byung Kee,Choi, Byung Chun,Jeong, Jung Hyun,Yi, Soung Soo Elsevier 2014 Spectrochimica acta. Part A, Molecular and biomole Vol.125 No.-
A series of new double perovskite tungstate Ba2CaWO6:xDy(3+) (0.01 <= x <= 0.15) phosphors were synthesized via solid state reaction process. XRD analysis confirmed the phase formation of Ba2CaWO6:Dy3+ materials. The photoluminescence excitation and emission spectra, concentration effect, thermal-quenching, and decay property were investigated. The phosphor could be excited by the UV light region from 250 to 400 nm, and it exhibits blue (493 nm) and yellow (584 nm) emission corresponding to F-4(9/2)-H-6(15/2) transitions and F-4(9/2)-H-6(13/2) transitions, respectively. The optimum dopant concentration of Dy3+ ions in Ba2CaWO6:xDy(3+) is around 5 mol% and the critical transfer distance of Dy3+ is calculated as 14 angstrom. The thermal-quenching temperature is 436 K for Ba2CaWO6:0.05Dy(3+). The fluorescence lifetime is also determined in Ba2CaWO6:0.05Dy(3+). (C) 2014 Elsevier B.V. All rights reserved.